The FDA has Awarded Over $18 Million for Rare Disease Research
kropekk_pl / Pixabay

The FDA has Awarded Over $18 Million for Rare Disease Research

The United States Food and Drug Administration has awarded twelve research grants worth a total of over $18 million for research into rare diseases. For more information about this news,…

Continue Reading The FDA has Awarded Over $18 Million for Rare Disease Research
Clinical Trial Data Looking Promising for an Experimental Amyotrophic Lateral Sclerosis Treatment
DarkoStojanovic / Pixabay

Clinical Trial Data Looking Promising for an Experimental Amyotrophic Lateral Sclerosis Treatment

According to a story from BioSpace, the biotechnology company BioElectron recently announced that the results from its Phase 2a clinical trial of its experimental product EPI-589 are looking positive. EPI-589…

Continue Reading Clinical Trial Data Looking Promising for an Experimental Amyotrophic Lateral Sclerosis Treatment

Cambridge Researchers Find That Gene Editing Could Help Treat Mitochondrial Diseases

According to a story from UPI, gene editing technology could be a potential treatment for mitochondrial diseases, a rare, genetic illness that is usually fatal. In a proof-of-concept experiment, researchers…

Continue Reading Cambridge Researchers Find That Gene Editing Could Help Treat Mitochondrial Diseases
Experimental Treatment Shuts Down Hereditary Angioedema Attacks Quickly in Trials
Free-Photos / Pixabay

Experimental Treatment Shuts Down Hereditary Angioedema Attacks Quickly in Trials

According to a story from Angioedema News, an investigational product from BioCryst Pharmaceuticals called BCX7353 was able to quickly subdue swelling attacks in hereditary angioedema in clinical trials. In addition,…

Continue Reading Experimental Treatment Shuts Down Hereditary Angioedema Attacks Quickly in Trials
Experimental Treatment for Peripheral T-Cell Lymphoma Gets Orphan Drug Designation
PDPics / Pixabay

Experimental Treatment for Peripheral T-Cell Lymphoma Gets Orphan Drug Designation

According to a story from globenewswire.com, the pharmaceutical company Portola Pharmaceuticals recently announced that its investigational product cerdulatinib has earned Orphan Drug designation from the US Food and Drug Administration…

Continue Reading Experimental Treatment for Peripheral T-Cell Lymphoma Gets Orphan Drug Designation
Close Menu